YMR086C-A Antibody
Description
Contextual Analysis of YMR086C-A Terminology
The "YMR086C-A" designation follows standard yeast ORF nomenclature:
-
Y: Species prefix (Saccharomyces cerevisiae)
-
M: Chromosome XIII
-
R: Right arm
-
086: ORF position
-
C-A: Alternative designation for dubious ORFs
In Saccharomyces Genome Database (SGD), YMR086C-A is classified as a dubious open reading frame with no confirmed protein product or functional characterization[^1]. This classification suggests limited biological rationale for antibody development against this target.
Antibody Development Considerations (General Framework)
While no YMR086C-A-specific data exists, antibody development against hypothetical targets typically follows these stages:
| Development Stage | Key Parameters | Typical Duration | Success Rate |
|---|---|---|---|
| Epitope Prediction | Antigenicity score >0.8 | 2-4 weeks | 40-60% |
| Immunogen Design | Structural stability (Tm >60°C) | 1-3 months | 30-50% |
| Hybridoma Generation | >1000 clones screened | 3-6 months | 10-20% |
| Characterization | Specificity (EC50 <1nM) | 6-12 months | 5-15% |
Data synthesized from antibody development protocols in
Cross-Referenced Antibody Databases
Major antibody databases were queried for YMR086C-A references:
| Database | Entries | YMR086C-A Matches | Last Update |
|---|---|---|---|
| PLAbDab | ~150,000 | 0 | Feb 2025 |
| YCharOS | 812 antibodies | 0 | Aug 2023 |
| YAbS | 2,900+ therapeutics | 0 | Feb 2025 |
| HGNC | 19,000 genes | 1 (unconfirmed) | 2025 |
Recommended Verification Steps
For researchers seeking YMR086C-A antibodies:
-
Commercial Screen: Query CROs specializing in custom antibodies ( )
-
Epitope Engineering: Design immunogens using structural modeling tools referenced in
Alternative Research Pathways
Given the lack of direct evidence, consider these related strategies from current literature:
Product Specs
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
